Martin Krššák
Martin Krššák
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study
M Krssak, K Falk Petersen, A Dresner, L DiPietro, SM Vogel, DL Rothman, ...
Diabetologia 42, 113-116, 1999
Mechanism by which metformin reduces glucose production in type 2 diabetes.
RS Hundal, M Krssak, S Dufour, D Laurent, V Lebon, V Chandramouli, ...
Diabetes 49 (12), 2063-2069, 2000
BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
F Hilberg, GJ Roth, M Krssak, S Kautschitsch, W Sommergruber, ...
Cancer research 68 (12), 4774-4782, 2008
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo
M Steegmaier, M Hoffmann, A Baum, P Lénárt, M Petronczki, M Krššák, ...
Current biology 17 (4), 316-322, 2007
Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
GW Cline, KF Petersen, M Krssak, J Shen, RS Hundal, Z Trajanoski, ...
New England Journal of Medicine 341 (4), 240-246, 1999
Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies
T Kurdiova, M Balaz, M Vician, D Maderova, M Vlcek, L Valkovic, ...
The Journal of physiology 592 (5), 1091-1107, 2014
Mechanism of amino acid-induced skeletal muscle insulin resistance in humans
M Krebs, M Krssak, E Bernroider, C Anderwald, A Brehm, M Meyerspeer, ...
Diabetes 51 (3), 599-605, 2002
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes
M Krssak, A Brehm, E Bernroider, C Anderwald, P Nowotny, CD Man, ...
Diabetes 53 (12), 3048-3056, 2004
Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle
A Brehm, M Krssak, AI Schmid, P Nowotny, W Waldhäusl, M Roden
Diabetes 55 (1), 136-140, 2006
Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes
J Szendroedi, AI Schmid, M Chmelik, C Toth, A Brehm, M Krssak, ...
PLoS medicine 4 (5), e154, 2007
Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13C and 1H Nuclear Magnetic Resonance …
M Krssak, KF Petersen, R Bergeron, T Price, D Laurent, DL Rothman, ...
The Journal of Clinical Endocrinology & Metabolism 85 (2), 748-754, 2000
Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.
M Roden, M Krssak, H Stingl, S Gruber, A Hofer, C Fürnsinn, E Moser, ...
Diabetes 48 (2), 358-364, 1999
Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise
D Laurent, KE Schneider, WK Prusaczyk, C Franklin, SM Vogel, M Krssak, ...
The Journal of Clinical Endocrinology & Metabolism 85 (6), 2170-2175, 2000
In utero tractography of fetal white matter development
G Kasprian, PC Brugger, M Weber, M Krssák, E Krampl, C Herold, ...
Neuroimage 43 (2), 213-224, 2008
5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement
G Widhalm, S Wolfsberger, G Minchev, A Woehrer, M Krssak, T Czech, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
Abnormal hepatic energy homeostasis in type 2 diabetes
J Szendroedi, M Chmelik, AI Schmid, P Nowotny, A Brehm, M Krssak, ...
Hepatology 50 (4), 1079-1086, 2009
Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes
AI Schmid, J Szendroedi, M Chmelik, M Krššák, E Moser, M Roden
Diabetes care 34 (2), 448-453, 2011
Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle
C Anderwald, E Bernroider, M Krssák, H Stingl, A Brehm, MG Bischof, ...
Diabetes 51 (10), 3025-3032, 2002
Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes
A Kautzky-Willer, M Krssak, C Winzer, G Pacini, A Tura, S Farhan, ...
Diabetes 52 (2), 244-251, 2003
Mechanism of troglitazone action in type 2 diabetes.
KF Petersen, M Krssak, S Inzucchi, GW Cline, S Dufour, GI Shulman
Diabetes 49 (5), 827-831, 2000
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20